期刊
DEVELOPMENTAL DYNAMICS
卷 237, 期 5, 页码 1295-1306出版社
WILEY-LISS
DOI: 10.1002/dvdy.21528
关键词
cornea; Pax6; gene dosage; anterior segment; wound healing
资金
- BBSRC [BB/E015840/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/E015840/1] Funding Source: researchfish
- Biotechnology and Biological Sciences Research Council [BB/E0158401/1, BB/E015840/1] Funding Source: Medline
- Wellcome Trust [074127] Funding Source: Medline
The requirement for correct dosage of the transcription factor Pax6 during corneal growth and development was investigated using the Pax6-overexpressing (PAX77) transgenic mouse. Transgenics had a microcornea phenotype due to failure of postnatal growth, associated with reduction in the number of cells layers in the corneal epithelium. Cell cycle progression was monitored using bromodeoxyuridine, p63, cyclin E, and phosphohistone-3 labeling: proliferation rates were higher in PAX77(+) than wild-type, without a concomitant increase in apoptosis. Hence, failure of proliferation did not underlie microcornea. PAX77(+) corneal epithelia had reduced levels of cytokeratin-12, and exhibited severe wound healing delay that, in contrast to Pax6(+/-) mice, could not be modulated by exogenous growth factors. PAX77(+) lenses showed partial failure of lens fiber differentiation. The data demonstrate that anterior eye development is very sensitive to Pax6 dosage. Although there are similarities between the eye phenotype of Pax6 heterozygotes and overexpressing mice, there are also striking differences.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据